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Abstract
Background: There is evidence to suggest that human papillomavirus (HPV) can cross the
placenta resulting in in-utero transmission. The goal of this study was to determine if HPV can be
detected in amniotic fluid from women with intact amniotic membranes.
Methods: Residual amniotic fluid and cultured cell pellets from amniocentesis performed for
prenatal diagnosis were used. PGMY09/11 L1 consensus primers and GP5+/GP6+ primers were
used in a nested polymerase chain reaction assay for HPV.
Results: There were 146 paired samples from 142 women representing 139 singleton pregnancies,
2 twin pregnancies, and 1 triplet pregnancy. The women were 78% Caucasian, 5% African
American, 14% Asian, and 2% Hispanic. The average age was 35.2 years with a range of 23–55 years.
All samples were β-globin positive. HPV was not detected in any of the paired samples.
Conclusion: Given the age range, race, and ethnicity of the study population, one would anticipate
some evidence of HPV if it could easily cross the placenta, but there was none.
Background
Infection with human papillomaviruses (HPV) is causal
in the development of genital and oral cancers [1,2]. HPV
infection is considered a sexually transmitted infection
among adolescents and adults [3]. Detection rates of HPV
infection by polymerase chain reaction (PCR) have
ranged widely between 1% and 20% in newborns of preg-
nant women without apparent infection in their cervix [4-
7] and between 5% and 72% in women with HPV-related
cervical diseases diagnosed during pregnancy [8]. Many
investigators believe that infants are exposed to HPV and
infected during vaginal delivery [9,10]. In contrast, some
investigators have suggested that vertical transmission is
possible without evidence of vaginal or cervical secretion
contact of the fetus [11-16]. However, the number of
women studied to confirm placental transmission of HPV
has been limited.
The goal of this study was to determine if HPV could be
detected in amniotic fluid from women with intact mem-
branes.
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Human subject approval from the University of Michigan
was obtained to use residual amniocentesis samples that
were to be discarded. To be eligible for the study, pregnant
women had to be undergoing clinically indicated amnio-
centesis and have intact membranes. The only informa-
tion on the women available to the investigators was age,
race/ethnicity, and number of fetuses present at time of
sampling. All clinical assays related to chromosomal
assessment of the fetus had been completed, and the
residual amniotic fluid and amniotic cell culture pellets
were retrieved from the cytogenetics laboratory.
Amniotic fluid samples (8–12 ml) were spun at 4500 rpm
for 30 minutes. After decanting the supernatant fluid, the
pellet was suspended in 150 μL of TrisEDTA buffer. The
cultured cell pellets were resuspended in 200 μL PBS. A
150 μL volume of each sample was extracted using the
Roche MagNA Pure LC instrument and the DNA isolation
kit I resulting in a final volume of 150 μL.
We used a direct PCR method followed by a nested PCR
method to detect HPV. The Roche line blot assay, based
on L1 consensus PCR with biotinylated PGMY09/11
primer sets and β-globin as an internal control for sample
amplification [17,18] was used as previously described,
with 10 μL extract in each 50 μL reaction. All samples were
HPV gel-band-negative and Roche Prototype Strip Assay-
negative after 40 cycles (reagents provided as a gift from
Roche Molecular Systems, Inc., Pleasanton, CA).
For the nested reaction, five microliters of each L1 ampli-
con was added to a PCR reaction mix containing GP5+/
GP6+ [19] primers (1 μM each) and run for an additional
40 cycles under the following conditions: 40 cycles of
94°C for 45 s, 48°C for 4 s, 38°C for 30 s, 42°C for 5 s,
66°C for 5 s, and 71°C for 1.5 min. This was followed by
a final extension of 10 min at 72°C. Fifteen μL from each
sample was analyzed on a 2% agarose gel.
The HPV assays were repeated using separate extractions,
increased volumes of extracts in the PCR assays and re-
amplification of L1 consensus PCR products with PGMY
primers.
The data was analyzed using SPSS 11 with frequency dis-
tributions of study participants by age, race, and ethnicity
by HPV status.
Results
The residual amniotic fluid and cell pellets were collected
from 142 women. There were 146 paired samples repre-
senting 138 singleton pregnancies, 2 twin pregnancies, 1
triplet pregnancy, and 1 singleton pregnancy with an egg
donor. The women's average age was 35.2 years with a
range from 23–55 years. The race and ethnicity was 78%
Caucasian, 5% African American, 14% Asian, and 2% His-
panic. No other data were available on the women. No
HPV was detected in any of the amniotic fluid or pellet
cell samples. All samples were β-globin positive. There
was no evidence of technical barriers to detecting HPV in
samples if it was present.
Discussion
In this study, no HPV was detected in amniotic fluid or
culture cell pellets from 142 pregnant women with intact
amniotic membranes. Other investigators have reported
the upper 95% confidence interval for detection of perina-
tal transmission from women with any evidence of genital
HPV is only 2.8% [7]. Worda and colleagues found no
HPV in amniotic fluid taken just prior to a cesarean deliv-
ery in 153 Austrian women with intact membranes [10].
With 142 amniotic samples, we have 80–85% power to
detect prevalence of HPV from 1% to 10%. Therefore, the
lack of detecting HPV in the amniotic samples is not due
to inadequate number of samples.
This study was not able to actually determine the HPV sta-
tus of the study participants or their risk for having HPV.
It is possible that none of the women had ever been
infected or were not currently infected with HPV. Other
studies addressing the issue of vertical transmission of
HPV have reported that 12–36% of pregnant women
asymptomatic for HPV were positive for HPV
[8,10,16,20]. The population characteristics of these stud-
ies were similar to this study with a reported age range of
18–45 years and primarily Caucasian women except stud-
ies conducted in Asian countries [8,10,16]. The similari-
ties between our study population and others suggest that
12–36% of the pregnant women should have been
infected with HPV [6,8,10,11,16,20,21]. Yet, no HPV was
detected in the amniotic fluid.
Conclusion
Perinatal transmission of HPV clearly does occur; juvenile
onset recurrent respiratory papillomatosis is a docu-
mented rare outcome of infection with HPV. This occurs
in 7 of every 1000 infants born to a mother with genital
warts [22]. Some investigators have suggested that infants
are exposed and infected by HPV during a vaginal delivery
[9]. Studies have documented that there is poor concord-
ance between parents' genital HPV and newborns' oral/
genital HPV [20]. In contrast, some investigators have sug-
gested that vertical transmission is possible without evi-
dence of vaginal or cervical secretion contact of the fetus
[11-15]. However, this study and others suggest that verti-
cal transmission without exposure to vaginal or cervical
secretions is extremely unlikely [8,10].Page 2 of 3
(page number not for citation purposes)
BMC Pregnancy and Childbirth 2006, 6:28 http://www.biomedcentral.com/1471-2393/6/28Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MR and JB participated in concept development, study
design, implementation, and coordination; data analysis,
and drafting the manuscript. DR collected the data and
coordinated the sample numbers with demographic data.
DRL, RAT, DCS, and ERU participated in the HPV assays
and drafting the manuscript.
Acknowledgements
The authors thank Kathleen Crawford for assistance in retrieving anony-
mous materials from the cytogenetics laboratory and Miriam Lawson, 
Sonya Patel, and Juanita Onyekwuluje for assistance with laboratory testing.
Drs. Ruffin and Bailey were supported by NCI Grant CA080846. The fund-
ing agency had no role in the study design, data collection, analysis, inter-
pretation of the data, writing of the manuscript or the decision to submit 
the manuscript for publication.
References
1. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush
BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK,
Manos MM: Epidemiologic evidence showing that Human
Papillomavirus infection causes most cervical intraepithelial
neoplasia.  J Natl Cancer Inst 1993, 85(12):958-964.
2. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L,
Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky
D: Evidence for a causal association between human papillo-
mavirus and a subset of head and neck cancers [see com-
ments].  J Natl Cancer Inst 2000, 92(9):709-720.
3. Munoz N: Human papillomavirus and cancer: the epidemio-
logical evidence.  J Clin Virol 2000, 19(1-2):1-5.
4. Pakarian F, Kaye J, Cason J, Kell B, Jewers R, Derias NW, Raju KS,
Best JM: Cancer associated human papillomaviruses: perina-
tal transmission and persistence.  Br J Obstet Gynaecol 1994,
101(6):514-517.
5. Syrjanen S, Puranen M: Human papillomavirus infections in chil-
dren: the potential role of maternal transmission.  Crit Rev Oral
Biol Med 2000, 11(2):259-274.
6. Puranen M, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S: Vertical
transmission of human papillomavirus from infected moth-
ers to their newborn babies and persistence of the virus in
childhood.  Am J Obstet Gynecol 1996, 174(2):694-699.
7. Watts DH, Koutsky LA, Holmes KK, Goldman D, Kuypers J, Kiviat
NB, Galloway DA: Low risk of perinatal transmission of human
papillomavirus: results from a prospective cohort study.  Am
J Obstet Gynecol 1998, 178(2):365-373.
8. Smith EM, Johnson SR, Cripe T, Perlman S, McGuinness G, Jiang D,
Cripe L, Turek LP: Perinatal transmission and maternal risks of
human papillomavirus infection.  Cancer Detect Prev 1995,
19(2):196-205.
9. Tseng CJ, Liang CC, Soong YK, Pao CC: Perinatal transmission of
human papillomavirus in infants: relationship between infec-
tion rate and mode of delivery.  Obstet Gynecol 1998,
91(1):92-96.
10. Worda C, Huber A, Hudelist G, Schatten C, Leipold H, Czerwenka
K, Eppel W: Prevalence of cervical and intrauterine human
papillomavirus infection in the third trimester in asympto-
matic women.  J Soc Gynecol Investig 2005, 12(6):440-444.
11. Puranen MH, Yliskoski MH, Saarikoski SV, Syrjanen KJ, Syrjanen SM:
Exposure of an infant to cervical human papillomavirus
infection of the mother is common.  Am J Obstet Gynecol 1997,
176(5):1039-1045.
12. Xu S, Liu L, Lu S, Ren S: Clinical observation on vertical trans-
mission of human papillomavirus.  Chin Med Sci J 1998,
13(1):29-31.
13. Favre M, Majewski S, De Jesus N, Malejczyk M, Orth G, Jablonska S:
A possible vertical transmission of human papillomavirus
genotypes associated with epidermodysplasia verruciformis.
J Invest Dermatol 1998, 111(2):333-336.
14. Wang X, Zhu Q, Rao H: Maternal-fetal transmission of human
papillomavirus.  Chin Med J (Engl) 1998, 111(8):726-727.
15. Tseng CJ, Lin CY, Wang RL, Chen LJ, Chang YL, Hsieh TT, Pao CC:
Possible transplacental transmission of human papillomavi-
ruses.  Am J Obstet Gynecol 1992, 166(1 Pt 1):35-40.
16. Deng D, Wen L, Chen W, Ling X: Asymptomatic genital infec-
tion of human papillomavirus in pregnant women and the
vertical transmission route.  J Huazhong Univ Sci Technolog Med Sci
2005, 25(3):343-345.
17. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM: Genotyping of 27
human papillomavirus types by using L1 consensus PCR
products by a single-hybridization, reverse line blot detec-
tion method.  J Clin Microbiol 1998, 36(10):3020-3027.
18. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hild-
esheim A, Schiffman MH, Scott DR, Apple RJ: Improved amplifica-
tion of genital human papillomaviruses.  J Clin Microbiol 2000,
38(1):357-361.
19. Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J, Hughes TK,
Stisser K, Konig R, Tyring SK: Nested PCR with the PGMY09/11
and GP5(+)/6(+) primer sets improves detection of HPV
DNA in cervical samples.  J Virol Methods 2004, 122(1):87-93.
20. Smith EM, Ritchie JM, Yankowitz J, Swarnavel S, Wang D, Haugen TH,
Turek LP: Human papillomavirus prevalence and types in
newborns and parents: concordance and modes of transmis-
sion.  Sex Transm Dis 2004, 31(1):57-62.
21. Puranen M, Syrjanen K, Syrjanen S: Transmission of genital
human papillomavirus infections is unlikely through the floor
and seats of humid dwellings in countries of high-level
hygiene.  Scand J Infect Dis 1996, 28(3):243-246.
22. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV: Condy-
loma in pregnancy is strongly predictive of juvenile-onset
recurrent respiratory papillomatosis.  Obstet Gynecol 2003,
101(4):645-652.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2393/6/28/prepubPage 3 of 3
(page number not for citation purposes)
